PATENT CLAIM ANALYSIS

Application Number: 15907619
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "234200"]

Abstract:
Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound and an effective amount of an androgen receptor antagonist to a patient having a cancer.

Claim (Index 5):
The method of  claim 1 , wherein the Dihydropyrazino-Pyrazine Compound is administrated in a unit dosage formulation comprising about 5 mg, about 7.5 mg or about 10 mg of the Dihydropyrazino-Pyrazine Compound in combination with an effective amount of MDV3100.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14254017', '15299589', '14254004', '15459111', '14254020']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7915512117314458
- 35 USC 102 Novelty (BERT): 0.6067614440322356
- Combined Prediction Score: 0.7730722349615248
- Mean Citation Score: 412.79469
- Max Citation Score: 586.8324
- Similarity Product: 470.8522075625896

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test